Originally isolated from bone marrow, mesenchymal stromal cells (MSCs) have since been
obtained from various fetal and post-natal tissues and are the focus of an increasing number …

Since the 1960s and the therapeutic use of hematopoietic stem cells of bone marrow origin,
there has been an increasing interest in the study of undifferentiated progenitors that have …

Introduction: Chemotherapy is the most commonly used modality to treat human cancers;
however, in many cases it causes irreversible ovarian failure. In this work, we plan to …

Although mesenchymal stem cells (MSCs) based therapy has been considered as a
promising tool for tissue repair and regeneration, the optimal cell source remains unknown …

Mesenchymal stem cells (MSCs) of placental origin have become increasingly translational
owing to their abundance and accessibility. MSCs of different origin share several features …

Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated
with several complications. Adipose tissue-derived mesenchymal stem cells (AT-MSCs) …

Background Many data are available on expansion protocols for mesenchymal stromal cells
(MSCs) for both experimental settings and manufacturing for clinical trials. However, there is …

Mesenchymal stem cells (MSCs) have extensive potentials, which make them attractive
candidates for the developmental biology, drug discovery and regenerative medicine …

Obesity contributes significantly to the global health burden. A better understanding of
adipogenesis, the process of fat formation, may lead to the discovery of novel treatment …

Mesenchymal stem cells (MSCs) isolated from adult human tissues are capable of
proliferating in vitro and maintaining their multipotency, making them attractive cell sources …